Melatonin modulates the fetal cardiovascular defense response to acute hypoxia

Journal of Pineal Research

Volumn 59, Issue 1, 2015, Pages 80-90

  Thakor, Avnesh S ^a,b   Allison, Beth J ^a   Niu, Youguo ^a   Botting, Kimberley J ^a   Serõn Ferré, Maria ^c   Herrera, Emilio A ^c   Giussani, Dino A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

cardiovascular; hypoxia; melatonin; nitric oxide; oxidative stress

Indexed keywords

ADRENALIN; CATECHOLAMINE; MELATONIN; NITRIC OXIDE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; BIOAVAILABILITY; BLOOD GAS ANALYSIS; BRAIN FUNCTION; CARDIOMETABOLIC DEFENSE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMORAL ARTERY FLOW; FETUS; FETUS BLOOD; FETUS CIRCULATION; FETUS HYPOXIA; GESTATION PERIOD; GLYCEMIC LOAD; IN VIVO STUDY; INTRAVASCULAR CATHETER; LOW DRUG DOSE; METABOLIC PARAMETERS; NONHUMAN; NORADRENALIN BLOOD LEVEL; OVINE MODEL; PATCH CLAMP TECHNIQUE; PEDIATRIC CARDIOLOGY; PERIPHERAL CIRCULATION; TREATMENT RESPONSE; ANIMAL; DRUG EFFECTS; FEMALE; HYPOXIA; METABOLISM; OXIDATIVE STRESS; PREGNANCY; SHEEP;

ANIMALS; CATECHOLAMINES; FEMALE; FETUS; HYPOXIA; MELATONIN; NITRIC OXIDE; OXIDATIVE STRESS; PREGNANCY; SHEEP;

EID: 84934284564     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12242     Document Type: Article

References (59)

1. Reiter RJ, Tamura H, Tan DX, et al., Melatonin and the circadian system: contributions to successful female reproduction. Fertil Steril 2014; 102: 321-328.
2. Kivela A,. Serum melatonin during human pregnancy. Acta Endocrinol 1991; 124: 233-237.
3. Lee CK, Moon DH, Shin CS, et al., Circadian expression of Mel1a and PL-II genes in placenta: effects of melatonin on the PL-II gene expression in the rat placenta. Mol Cell Endocrinol 2003; 200: 57-66.
4. Bonnefont-Rousselot D, Collin F,. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010; 278: 55-67.
5. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
6. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
7. Lopez A, Garcia JA, Escames G, et al., Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009; 46: 188-198.
8. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
9. Thakor AS, Herrera EA, Seron-Ferre M, et al., Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. J Pineal Res 2010; 49: 399-406.
10. Lemley CO, Meyer AM, Camacho LE, et al., Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol 2012; 302: R454-R467.
11. Tare M, Parkington HC, Wallace EM, et al., Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs. J Physiol 2014; 592: 2695-2709.
12. Lanoix D, Lacasse AA, Reiter RJ, et al., Melatonin: the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis. Mol Cell Endocrinol 2013; 381: 35-45.
13. Alers NO, Jenkin G, Miller SL, et al., Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction-a phase I pilot clinical trial: study protocol. BMJ Open 2013; 3: e004141.
14. Jones CT, Ritchie JW,. Endocrine and metabolic changes associated with periods of spontaneous hypoxia in fetal sheep. Biol Neonate 1976; 29: 286-293.
15. Cohn HE, Sacks EJ, Heymann MA, et al., Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol 1974; 120: 817-824.
16. Giussani D, Spencer J, Hanson M,. Fetal cardiovascular reflex responses to hypoxia. Fetal Mater Med Rev 1994; 6: 17-37.
17. Giussani DA, Spencer JA, Moore PJ, et al., Afferent and efferent components of the cardiovascular reflex responses to acute hypoxia in term fetal sheep. J Physiol 1993; 461: 431-449.
18. Jones CT, Robinson RO,. Plasma catecholamines in foetal and adult sheep. J Physiol 1975; 248: 15-33.
19. Fletcher AJ, Gardner DS, Edwards CM, et al., Development of the ovine fetal cardiovascular defense to hypoxemia towards full term. Am J Physiol Heart Circ Physiol 2006; 291: H3023-H3034.
20. Thakor AS, Richter HG, Kane AD, et al., Redox modulation of the fetal cardiovascular defence to hypoxaemia. J Physiol 2010; 588: 4235-4247.
21. Thomas SR, Chen K, Keaney JF Jr,. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal 2003; 5: 181-194.
22. Giussani DA, Camm EJ, Niu Y, et al., Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS ONE 2012; 7: e31017.
23. Kane AD, Hansell JA, Herrera EA, et al., Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy. J Physiol 2014; 592: 475-489.
24. Gardner DS, Giussani DA,. Enhanced umbilical blood flow during acute hypoxemia after chronic umbilical cord compression: a role for nitric oxide. Circulation 2003; 108: 331-335.
25. Gardner DS, Fowden AL, Giussani DA,. Adverse intrauterine conditions diminish the fetal defense against acute hypoxia by increasing nitric oxide activity. Circulation 2002; 106: 2278-2283.
26. Thakor AS, Giussani DA,. Role of nitric oxide in mediating in vivo vascular responses to calcitonin gene-related peptide in essential and peripheral circulations in the fetus. Circulation 2005; 112: 2510-2516.
27. Fletcher AJ, Goodfellow MR, Forhead AJ, et al., Low doses of dexamethasone suppress pituitary-adrenal function but augment the glycemic response to acute hypoxemia in fetal sheep during late gestation. Pediatr Res 2000; 47: 684-691.
28. Fischer TW, Scholz G, Knoll B, et al., Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res 2001; 31: 39-45.
29. Fischer TW, Scholz G, Knoll B, et al., Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J Pineal Res 2004; 37: 107-112.
30. Herxheimer A, Petrie KJ,. Melatonin for preventing and treating jet lag. Cochrane Database Syst Rev 2001: CD001520.
31. Fletcher AJ, McGarrigle HH, Edwards CM, et al., Effects of low dose dexamethasone treatment on basal cardiovascular and endocrine function in fetal sheep during late gestation. J Physiol 2002; 545: 649-660.
32. Matthews JN, Altman DG, Campbell MJ, et al., Analysis of serial measurements in medical research. BMJ 1990; 300: 230-235.
33. Richter HG, Hansell JA, Raut S, et al., Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res 2009; 46: 357-364.
34. Shukla P, Lemley CO, Dubey N, et al., Effect of maternal nutrient restriction and melatonin supplementation from mid to late gestation on vascular reactivity of maternal and fetal placental arteries. Placenta 2014; 35: 461-466.
35. Shukla P, Sun C, O'Rourke ST,. Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries. Am J Physiol Heart Circ Physiol 2012; 303: H1418-H1425.
36. Miller SL, Yawno T, Alers NO, et al., Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J Pineal Res 2014; 56: 283-294.
37. Herrera EA, MacChiavello R, Montt C, et al., Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. J Pineal Res 2014; 57: 33-42.
38. Tain YL, Huang LT, Hsu CN, et al., Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction. Oxid Med Cell Longev 2014; 2014: 283180.
39. Tain YL, Chen CC, Sheen JM, et al., Melatonin attenuates prenatal dexamethasone-induced blood pressure increase in a rat model. J Am Soc Hypertens 2014; 8: 216-226.
40. Tijsseling D, Camm EJ, Richter HG, et al., Statins prevent adverse effects of postnatal glucocorticoid therapy on the developing brain in rats. Pediatr Res 2013; 74: 639-645.
41. Niu Y, Herrera EA, Evans RD, et al., Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy. J Physiol 2013; 591: 5083-5093.
42. Herrera EA, Verkerk MM, Derks JB, et al., Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats. PLoS ONE 2010; 5: e9250.
43. Chen YC, Sheen JM, Tiao MM, et al., Roles of melatonin in fetal programming in compromised pregnancies. Int J Mol Sci 2013; 14: 5380-5401.
44. Arangino S, Cagnacci A, Angiolucci M, et al., Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999; 83: 1417-1419.
45. Seron-Ferre M, Reynolds H, Mendez NA, et al., Impact of maternal melatonin suppression on amount and functionality of brown adipose tissue (BAT) in the newborn sheep. Front Endocrinol 2014; 5: 232.
46. K-Laflamme A, Wu L, Foucart S, et al., Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 219-229.
47. Wang M, Yokotani K, Nakamura K, et al., Melatonin inhibits the central sympatho-adrenomedullary outflow in rats. Jpn J Pharmacol 1999; 81: 29-33.
48. Chuang JI, Chen SS, Lin MT,. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology 1993; 47: 91-97.
49. Esquifino AI, Moreno ML, Steger RW,. Effects of chronic melatonin administration on adrenal medulla catecholamine metabolism in adult male golden hamsters. J Pineal Res 1994; 16: 154-158.
50. Boyle DW, Meschia G, Wilkening RB,. Metabolic adaptation of fetal hindlimb to severe, nonlethal hypoxia. Am J Physiol 1992; 263: R1130-R1135.
51. Jones CT, Ritchie JW, Walker D,. The effects of hypoxia on glucose turnover in the fetal sheep. J Dev Physiol 1983; 5: 223-235.
52. Hooper SB,. Fetal metabolic responses to hypoxia. Reprod Fertil Dev 1995; 7: 527-538.
53. Sadowsky DW, Yellon S, Mitchell MD, et al., Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142 days gestation (term = 147 days gestation). Endocrinology 1991; 128: 1812-1818.
54. Klein DC,. Evidence for the placental transfer of 3 H-acetyl-melatonin. Nat New Biol 1972; 237: 117-118.
55. Reppert SM, Chez RA, Anderson A, et al., Maternal-fetal transfer of melatonin in the non-human primate. Pediatr Res 1979; 13: 788-791.
56. Okatani Y, Okamoto K, Hayashi K, et al., Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 1998; 25: 129-134.
57. Francis PL, Leone AM, Young IM, et al., Gas chromatographic-mass spectrometric assay for 6-hydroxymelatonin sulfate and 6-hydroxymelatonin glucuronide in urine. Clin Chem 1987; 33: 453-457.
58. Van Bel F, Sola A, Roman C, et al., Role of nitric oxide in the regulation of the cerebral circulation in the lamb fetus during normoxemia and hypoxemia. Biol Neonate 1995; 68: 200-210.
59. Rowell LB, Blackmon JR,. Human cardiovascular adjustments to acute hypoxaemia. Clin Physiol 1987; 7: 349-376.